Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2025-11-02 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 10-Q for the Quarter Ended September 30, 2025 42 pages 486.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-Q' and explicitly states it is a 'QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934' for the quarterly period ended September 30, 2025. It contains detailed unaudited condensed consolidated financial statements including balance sheets, statements of operations, comprehensive income, changes in equity, and cash flows, as well as management's discussion and analysis. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual quarterly report, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-11-02 English
Resmed Announces Results for the First Quarter of FY2026 10 pages 469.4KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026' and contains detailed financial data including revenue, gross margin, income from operations, net income, earnings per share, and cash flow statements for the quarter ended September 30, 2025. It includes both GAAP and non-GAAP financial measures, segment revenue breakdowns, and operational highlights. The document also references a webcast of the earnings call and provides a detailed discussion of quarterly results. The presence of comprehensive financial statements and analysis for a fiscal quarter clearly identifies this as a quarterly earnings report. It is not merely an announcement or a brief summary but contains substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2025-10-30 English
Dividend/Distribution - RMD 4 pages 15.8KB
Notice of Dividend Amount Classification · 100% confidence The document is titled 'Appendix 3A.1 - Notification of dividend / distribution' and contains detailed information about a dividend payment, including the dividend amount, ex-date, record date, payment date, currency, and tax withholding rate. It specifically announces the dividend amount of USD 0.060 per share and provides related dates and conditions. The document is concise (4567 characters) and focuses solely on dividend details without including broader financial statements or analysis. This matches the definition of a 'Notice of Dividend Amount' filing, which announces dividend amounts, payment dates, and details for shareholders.
2025-10-30 English
Resmed to Report First Quarter Fiscal 2026 Results 1
Earnings Release Classification · 95% confidence The document is a short announcement stating that Resmed will report its first quarter fiscal 2026 earnings on October 30, 2025, and that a webcast will be held to discuss the results. It does not contain any actual financial data or detailed financial statements. The document is primarily an earnings release announcement and webcast invitation, not the earnings report itself or a transcript. Given the length (2136 characters) and content, it fits the definition of an Earnings Release (ER) as it announces quarterly financial results and related webcast details. Q1 2026
2025-10-09 English
144 Report of proposed sale of securities 3 pages 140.1KB
Director's Dealing Classification · 100% confidence The document is a Form 144 filing with the SEC, which is a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. It details the sale of securities by an insider or affiliate, including the number of shares, dates, and broker information. This type of filing is specifically related to insider transactions and personal share dealings by company directors or executives. It is not an annual report, earnings release, or any other financial report. Therefore, it fits the definition of Director's Dealing (DIRS). The document length and content confirm it is the actual filing, not just an announcement or certification.
2025-10-08 English
4 Statement of changes in beneficial ownership of securities 2 pages 12.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the U.S. Securities and Exchange Commission, which reports changes in beneficial ownership of company securities by insiders such as officers, directors, or significant shareholders. It details a transaction by Michael J. Rider, the Global General Counsel of ResMed Inc, involving the disposal of common stock. Form 4 filings are specifically used to disclose insider transactions and are not financial reports, earnings releases, or other types of filings. Therefore, this document fits the category of Director's Dealing (DIRS). The document length and content confirm it is a full Form 4 filing, not just an announcement or certification.
2025-10-08 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.